Weigang Yuan

950 total citations · 1 hit paper
11 papers, 782 citations indexed

About

Weigang Yuan is a scholar working on Epidemiology, Molecular Biology and Geriatrics and Gerontology. According to data from OpenAlex, Weigang Yuan has authored 11 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 4 papers in Molecular Biology and 4 papers in Geriatrics and Gerontology. Recurrent topics in Weigang Yuan's work include Sirtuins and Resveratrol in Medicine (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Autophagy in Disease and Therapy (3 papers). Weigang Yuan is often cited by papers focused on Sirtuins and Resveratrol in Medicine (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Autophagy in Disease and Therapy (3 papers). Weigang Yuan collaborates with scholars based in China, United States and United Kingdom. Weigang Yuan's co-authors include Chunxu Wang, Jiahui Lei, Pei He, Chongyang Zhang, Chuanrui Xu, Robert J. Lee, Huiying Xue, Xingxing He, Yueguang Rong and Lei Li and has published in prestigious journals such as The Journal of Cell Biology, PLoS ONE and Nature Cell Biology.

In The Last Decade

Weigang Yuan

11 papers receiving 775 citations

Hit Papers

Liver fibrosis and hepati... 2016 2026 2019 2022 2016 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets
    2016 477 citations Chongyang Zhang, Weigang Yuan et al. World Journal of Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weigang Yuan China 8 390 316 273 126 89 11 782
Jacopo Baglieri United States 11 426 1.1× 441 1.4× 324 1.2× 121 1.0× 127 1.4× 11 947
Xuehua Sun China 17 245 0.6× 186 0.6× 338 1.2× 123 1.0× 109 1.2× 49 877
Shun Zhou China 16 264 0.7× 142 0.4× 375 1.4× 110 0.9× 112 1.3× 27 835
Mitsutaka Miura Japan 16 194 0.5× 283 0.9× 314 1.2× 40 0.3× 119 1.3× 30 707
P J De Bleser Belgium 9 385 1.0× 504 1.6× 281 1.0× 38 0.3× 179 2.0× 9 841
Feizhou Huang China 15 258 0.7× 81 0.3× 587 2.2× 471 3.7× 88 1.0× 28 978
Hongmei Cui China 19 158 0.4× 89 0.3× 712 2.6× 513 4.1× 94 1.1× 34 1.1k
Zhuanchang Wu China 19 186 0.5× 98 0.3× 432 1.6× 213 1.7× 68 0.8× 32 838

Countries citing papers authored by Weigang Yuan

Since Specialization
Citations

This map shows the geographic impact of Weigang Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weigang Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weigang Yuan more than expected).

Fields of papers citing papers by Weigang Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weigang Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weigang Yuan. The network helps show where Weigang Yuan may publish in the future.

Co-authorship network of co-authors of Weigang Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Weigang Yuan. A scholar is included among the top collaborators of Weigang Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weigang Yuan. Weigang Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Zhang, Mi, Weigang Yuan, Chun Li, et al.. (2025). Resveratrol and N-acetylcystein reduce hepatic steatosis but enhance initiation and progression of hepatocellular carcinoma by inhibiting GST-pi-MAPK axis in mice. Frontiers in Pharmacology. 16. 1574039–1574039. 1 indexed citations
2.
Rong, Yueguang, Nilay Nandi, Linsen Li, et al.. (2022). STING controls energy stress-induced autophagy and energy metabolism via STX17. The Journal of Cell Biology. 221(7). 48 indexed citations
3.
Du, Wanqing, Weigang Yuan, Rui Tian, et al.. (2022). Recycling of autophagosomal components from autolysosomes by the recycler complex. Nature Cell Biology. 24(4). 497–512. 64 indexed citations
4.
Yuan, Weigang, et al.. (2022). Bifendate inhibits autophagy at multiple steps and attenuates oleic acid-induced lipid accumulation. Biochemical and Biophysical Research Communications. 631. 115–123. 10 indexed citations
5.
Yuan, Weigang, Mi Zhang, Chunxu Wang, et al.. (2022). Resveratrol Attenuates High-Fat Diet–Induced Hepatic Lipotoxicity by Upregulating Bmi-1 Expression. Journal of Pharmacology and Experimental Therapeutics. 381(2). 96–105. 17 indexed citations
6.
Yuan, Weigang, et al.. (2020). Recent advances in molecular mechanisms of autophagosome-lysosome fusion and impacts of exogenous factors. Duo Research Archive (University of Oslo). 2 indexed citations
7.
Xue, Huiying, Yong Liu, Weigang Yuan, et al.. (2017). Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma. International Journal of Nanomedicine. Volume 12. 5271–5287. 72 indexed citations
8.
Zhang, Chongyang, Weigang Yuan, Jianguo Fang, et al.. (2016). Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials. PLoS ONE. 11(8). e0161792–e0161792. 38 indexed citations
9.
Zhang, Chongyang, Weigang Yuan, Pei He, Jiahui Lei, & Chunxu Wang. (2016). Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets. World Journal of Gastroenterology. 22(48). 10512–10512. 477 indexed citations breakdown →
10.
Xue, Huiying, Yong Liu, Jiazhi Liao, et al.. (2016). Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma. Oncotarget. 7(52). 86675–86686. 51 indexed citations
11.
Luo, Hongbo R., Bin Li, Weigang Yuan, & Chuanrui Xu. (2015). Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis. Journal of Huazhong University of Science and Technology [Medical Sciences]. 35(5). 730–735. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacopo Baglieri Breakdown of academic impact, for papers by Xuehua Sun Breakdown of academic impact, for papers by Shun Zhou Breakdown of academic impact, for papers by Mitsutaka Miura Breakdown of academic impact, for papers by P J De Bleser Breakdown of academic impact, for papers by Feizhou Huang Breakdown of academic impact, for papers by Hongmei Cui Breakdown of academic impact, for papers by Zhuanchang Wu
Rankless by CCL
2026